• Islet Cell Cytoplasmic Antibody, IgG
  • Oncology Pharmacogenetics (PGx) Gene Variation Panel
  • Extractable Nuclear Antigen Antibody Panel (Autoantibodies in Connective Tissue Diseases)
  • Russell-Silver syndrome
  • ANKK1/DRD2
  • Complement Component C3, Serum
  • Mycoplasma pneumoniae, Culture
  • TERT (Telomerase Reverse Transcriptase) Gene Mutation Analysis
  • Maple Syrup Disease Genetic Testing
  • Hereditary Hemorrhagic Telangiectasia, ENG Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Hematolymphoid Neoplasm Gene Mutation Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Hematolymphoid Neoplasm Gene Mutation Panel, NGS
Medical Test

Interpretation
Access to Hematolymphoid Neoplasm Gene Mutation Panel, NGS is restricted.